Oncology Briefings: Updates in Therapeutic Options and Approaches for Tenosynovial Giant Cell Tumors (TGCT)
WebcastFaculty
OVERVIEW
Oncology Briefings: Updates in Therapeutic Options and Approaches for Tenosynovial Giant Cell Tumors (TGCT) is organized by Physicians Education Resource, LLC (PER) and will be held during Apr 28, 2017 - Apr 28, 2018.
The target audience for this medical event is directed toward medical oncologists, surgeons, rheumatologists, and hematologists who treat patients with TGCT. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, fellows, and other healthcare professionals interested in the treatment of such malignancies will also be invited to participate. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.
Conference Overview :
The Oncology Briefings is an online interactive monograph that will include an overview of the pathophysiology of tenosynovial giant cell tumors (TGCT) in addition to a review of recent data regarding treatments in patients with TGCT, designed to aid physicians in applying those findings to their practices. Commentary by a thought leader, key take-home points, and pearls for practice will place the content into perspective.
Conference Objectives :
At the conclusion of this activity, you should be better prepared to:
• Identify recent advancements in the understanding of TGCT pathogenesis
• Evaluate current clinical trial efficacy and safety data of novel pharmacologic therapies for TGCT
• Develop evidence-based treatment plans for the various forms of TGCT
• Describe the role of multidisciplinary management as a best practice to optimize outcomes for patients with TGCT
Additional details will be posted as soon as they are available.
The target audience for this medical event is directed toward medical oncologists, surgeons, rheumatologists, and hematologists who treat patients with TGCT. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, fellows, and other healthcare professionals interested in the treatment of such malignancies will also be invited to participate. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.
Conference Overview :
The Oncology Briefings is an online interactive monograph that will include an overview of the pathophysiology of tenosynovial giant cell tumors (TGCT) in addition to a review of recent data regarding treatments in patients with TGCT, designed to aid physicians in applying those findings to their practices. Commentary by a thought leader, key take-home points, and pearls for practice will place the content into perspective.
Conference Objectives :
At the conclusion of this activity, you should be better prepared to:
• Identify recent advancements in the understanding of TGCT pathogenesis
• Evaluate current clinical trial efficacy and safety data of novel pharmacologic therapies for TGCT
• Develop evidence-based treatment plans for the various forms of TGCT
• Describe the role of multidisciplinary management as a best practice to optimize outcomes for patients with TGCT
Additional details will be posted as soon as they are available.
SPECIALITIES
Oncology
Quick Links